In the News

Canfield’s VECTRA® WB360 assists INOVA Melanoma and Skin Cancer Center with patient surveillance and clinical research

Canfield’s VECTRA WB360 3D whole-body imaging system has been assisting doctors and specialists at INOVA Melanoma and Skin Cancer Center as they screen patients for skin cancer and conduct melanoma research. Since its installation in February 2019, the WB360 has provided body mapping technology and advanced 3D research tools to INOVA’S team of board certified dermatologists, oncologists, surgeons and pathologists. The VECTRA WB360’s non-polarized and cross-polarized images assist Dr. Suraj Venna, Director of the INOVA Melanoma and Skin Cancer Center, and fellow team members to identify skin changes quickly using the system’s automatic AI-driven lesion change technology. The VECTRA WB360 enables INOVA’s clinicians, physicians, and researchers to provide an unparalleled level of care for their patients. 

Canfield’s VECTRA® WB360 installed at the Skin Cancer Unit at Hospital Clinic de Barcelona, providing 3D whole-body imaging for Prof. Josep Malvehy and Dr. Susana Puig

Canfield’s VECTRA® WB360 3D whole-body imaging system was recently installed at the Skin Cancer Unit at the Hospital Clinic de Barcelona. The whole-body imaging system will assist Prof. Josep Malvehy, Dr. Susana Puig, and their colleagues as they capture patient images and track pigmented lesions on the skin’s surface. Prof. Malvehy is the Director of the Clinic’s Skin Care Unit and a world-renowned leader in the research, diagnosis, and treatment of skin cancer. Dr. Susanna Puig is the Head of the Dermatology Service and an expert in the diagnosis and treatment of melanoma and other skin cancers, while also specializing in confocal microscopy. Both Prof. Malvehy and Dr. Susana Puig are responsible for the introduction and validation of numerous diagnostic techniques for skin cancer and have published more than 400 research articles on the subject in international journals. The newly installed VECTRA WB360 system will provide Prof. Malvehy and Dr. Puig advanced body mapping technology and information from patient images that can further their clinical research. This installation is the second VECTRA WB360 system in Spain, with the first installed in Madrid at Grupo de Dermatologia Pedro Jaen where it is currently being used by Prof. Salvador Gonzalez.

Canfield’s VECTRA WB360® featured on Seven Network’s Sunrise morning show considered a “major breakthrough” in melanoma surveillance

Australia’s Seven Network Sunrise morning show featured the VECTRA WB360® whole-body 3D imaging system as a “technological breakthrough” for melanoma surveillance. Hosts David Koch and Natalie Barr discuss the whole-body imaging system with Associate Prof. Victoria Mar of Monash University in Melbourne, where she explains how the system’s advanced body mapping technology assists doctors in making more accurate melanoma diagnoses. Prof. Mar also mentions the infrastructure grant from the Australian Cancer Research Foundation, where 15 VECTRA WB360 systems will be placed in clinics across Queensland, New South Wales, and Victoria. The systems set up in these states will be part of a larger telehealth network, enabling patients in remote areas to take part in a very thorough risk assessment study. Prof. Mar explains how the approach using the VECTRA WB360 will help researchers monitor melanoma on a long-term basis and will place an emphasis on reaching remote patients so they can receive the highest level of care.

Canfield’s VECTRA WB360®, VISIA® provide doctors with advanced technology to assess and educate their patients on the effects of prolonged sun exposure

Cutting edge technology is making whole body screening easier than ever for both doctors and patients. Canfield's VECTRA WB360 3D whole-body imaging system provides doctors with the technology to examine their patients efficiently for signs of sun damage and melanoma, reducing unnecessary biopsies and procedures.  Dr. Steven Q. Wang, director of Dermatologic Surgery and Dermatology at Memorial Sloan Kettering Cancer Center shared, “the benefit to the patient is you don’t have to get all those benign lesions taken out.”

Canfield’s VECTRA WB360® combines advanced 3D-body mapping technology with A.I. to assist Baptist Health doctors with melanoma screenings

Canfield’s VECTRA WB360® provides doctors at Baptist Health in Miami advanced body mapping technology as they monitor patients for the earliest signs of melanoma. The advanced imaging system includes 92 cameras flashing simultaneously, with cross-polarized and polarized lighting to reveal all skin features. Naiara Braghiroli, MD, PHD, explains that with the VECTRA’s advanced body mapping technology, doctors at Baptist Health can create a 3D avatar of their patient, and “can navigate every single lesion and every part of the skin”.  Additionally, DermaGraphix® software includes DEXI, an explainable A.I. algorithm, that allows doctors using the VECTRA WB360 to view and track changes in lesions for a “second opinion” before making their ultimate diagnosis.

VECTRA® 3D Imaging Used in Experimental Study to Measure the Effects of Injectables and Facial Fillers

Canfield’s VECTRA 3D imaging system has been used to assist researchers as they conducted an experimental study focused on the effects of injectables and facial fillers. The study suggested that dermal fillers’ “volumizing” effects may also lead to subsequent “lifting effects”, as it suggests that lateral facial injections co-influence adjacent lateral facial regions. Sebastian Cotofana, MD, PhD and his team at the Mayo Clinic in Rochester, Minnesota measured the effects of the injections on specially prepared specimens by using VECTRA 3D imaging. The before-and-after scans from the VECTRA system showed that the dermal fillers led to significant increases in local soft tissue volume and local lifting effects on central facial injection areas, including “up to one millimeter of vertical ‘lift’ in the forehead area”.  

 Canfield’s VECTRA WB180® is a “game-changer”, per Mount Sinai Hospital

Doctors at Mount Sinai’s Waldman Melanoma Center use Canfield’s VECTRA WB180® 3D whole-body imaging system to screen patients for the earliest signs of skin cancer, as they spread awareness during Melanoma May. Canfield’s VECTRA WB180 imaging system captures 3D bodymap images with non-polarized and cross-polarized lighting for an enhanced view of lesions on the surface of the skin. The high-quality standardized images allow doctors at the Waldman Center to identify and track suspicious lesions automatically using advanced AI tools. Richard Torbek of Mount Sinai’s Icahn’s School of Medicine cites the VECTRA WB180 as a “game-changer” in skin cancer surveillance, as the system assists Mount Sinai’s doctors in melanoma prevention and detection. 

VECTRA WB180® provides 3D whole-body imaging at Mount Sinai’s new Melanoma and Skin Cancer Center.

Canfield’s VECTRA WB180 has been introduced at Mount Sinai Hospital as part of a larger initiative by the dermatology department to establish a new Melanoma and Skin Cancer Center. The whole-body imaging system uses AI-driven 3D-body mapping technology to track pigmented lesions on the skin’s surface. The VECTRA WB180 will assist Mount Sinai’s staff and highly trained specialists with providing patients the highest quality of care through the early detection and treatment of melanoma. In addition,  Mount Sinai’s researchers will be using the VECTRA WB180 alongside other advanced technologies to explore new skin cancer therapies and research approaches.

VISIA® Featured in ELLE Germany Magazine

In the latest April 2021 issue of ELLE Germany, Beauty Editor Sarah Vogelsang discusses how VISIA Skin Analysis helps her get to know her skin better. She reviews the extensive functions and analysis tools VISIA has to offer, and talks about how impressive the results are. 

VISIA® named in Lipgloss & Aftershave’s 2021 Tech Tool Box

VISIA® has been named in Lipgloss & Aftershave’s 2021 Tech Tool Box, which highlights the most unique skin care innovations and cutting edge technology in the professional skin care industry.